Abiopharma

🔍 Caswell Ryan R. (Executive)

Company: Cannae Holdings, Inc. (CNNE)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 33,333 shares of Restricted Stock Units (Direct)
  Date: 2026-08-13 | Code: D | equity_swap_involved: 0 | shares_owned_after: 366,667.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 33,333 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 323,014.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 13,116 shares of Common Stock at $15.56 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 309,898.00 | transaction_form_type: 4

Footnotes:

• F1: Upon the vesting of a portion of the restricted stock units granted to the reporting person on August 13, 2025, the reporting person received 33,333 shares of common stock of the company. As a result, the reporting person is reporting the disposition of 33,333 restricted stock units in exchange for an equal number of shares of common stock.